PMID- 37392767 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231010 IS - 2694-1902 (Electronic) IS - 2694-1902 (Linking) VI - 6 IP - 1 DP - 2023 Jul 3 TI - Detailed molecular and pathological analyses of primary intracranial embryonal rhabdomyosarcoma with a BRAF mutation: illustrative case. LID - CASE23207 [pii] LID - 10.3171/CASE23207 [doi] AB - BACKGROUND: The etiological significance of the RAS and PI3K pathways has been reported in systemic embryonal rhabdomyosarcoma (ERMS) but not in primary intracranial ERMS (PIERMS). Herein, the authors present a unique case of PIERMS with a BRAF mutation. OBSERVATIONS: A 12-year-old girl with progressive headache and nausea was diagnosed with a tumor in the right parietal lobe. Semi-emergency surgery revealed an intra-axial lesion that was histopathologically identical to an ERMS. Next-generation sequencing indicated a BRAF mutation as a pathogenic variation, but the RAS and PI3K pathways showed no alteration. Although there is no established reference class for PIERMS, the DNA methylation prediction was closest to that of ERMS, indicating the possibility of PIERMS. The final diagnosis was PIERMS. The patient underwent local radiotherapy (50.4 Gy) and multiagent chemotherapy, with no recurrence for 12 months after surgery. LESSONS: This may be the first case demonstrating the molecular features of PIERMS, especially the intra-axial type. The results showed a mutation in BRAF but not in the RAS and PI3K pathways, which is different from the existing ERMS features. This molecular difference may cause differences in DNA methylation profiles. Accumulation of the molecular features of PIERMS is necessary before any conclusions can be drawn. FAU - Abe, Masamichi AU - Abe M AD - Departments of1Neurosurgery and. FAU - Ono, Takahiro AU - Ono T AD - Departments of1Neurosurgery and. FAU - Hinz, Felix AU - Hinz F AD - 2Department for Neuropathology, Heidelberg University Hospital, Heidelberg, Germany. AD - 3Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany; and. FAU - Takahashi, Masataka AU - Takahashi M AD - Departments of1Neurosurgery and. FAU - Hiroshima, Yuko AU - Hiroshima Y AD - 4Department of Clinical Pathology, Akita University Hospital, Akita, Japan. FAU - Kodama, Koya AU - Kodama K AD - 5Pediatrics, Akita University Graduate School of Medicine, Akita, Japan. FAU - Yano, Michihiro AU - Yano M AD - 5Pediatrics, Akita University Graduate School of Medicine, Akita, Japan. FAU - Nanjo, Hiroshi AU - Nanjo H AD - 4Department of Clinical Pathology, Akita University Hospital, Akita, Japan. FAU - Takahashi, Tsutomu AU - Takahashi T AD - 5Pediatrics, Akita University Graduate School of Medicine, Akita, Japan. FAU - von Deimling, Andreas AU - von Deimling A AD - 2Department for Neuropathology, Heidelberg University Hospital, Heidelberg, Germany. AD - 3Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany; and. FAU - Shimizu, Hiroaki AU - Shimizu H AD - Departments of1Neurosurgery and. LA - eng PT - Journal Article DEP - 20230703 PL - United States TA - J Neurosurg Case Lessons JT - Journal of neurosurgery. Case lessons JID - 9918227275606676 PMC - PMC10555630 OTO - NOTNLM OT - BRAF OT - intra-axial tumor OT - methylation profile OT - next-generation sequencing OT - rhabdomyosarcoma COIS- Disclosures Dr. von Deimling reported a patent for a DNA-methylation-based method for classifying tumor species EP16710700 issued. EDAT- 2023/07/02 01:10 MHDA- 2023/07/02 01:11 PMCR- 2023/07/03 CRDT- 2023/07/01 19:02 PHST- 2023/04/15 00:00 [received] PHST- 2023/05/15 00:00 [accepted] PHST- 2023/07/02 01:11 [medline] PHST- 2023/07/02 01:10 [pubmed] PHST- 2023/07/01 19:02 [entrez] PHST- 2023/07/03 00:00 [pmc-release] AID - CASE23207 [pii] AID - 10.3171/CASE23207 [doi] PST - epublish SO - J Neurosurg Case Lessons. 2023 Jul 3;6(1):CASE23207. doi: 10.3171/CASE23207. Print 2023 Jul 3.